APOE Antikörper (AA 220-270)
Kurzübersicht für APOE Antikörper (AA 220-270) (ABIN5689876)
Target
Alle APOE Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 220-270
-
Aufreinigung
- APO-E Antibody is affinity chromatography purified via peptide column.
-
Immunogen
-
APO-E antibody was raised against a 19 amino acid peptide near the carboxy terminus of human APO-E.
The immunogen is located within amino acids 220 - 270 of APO-E. -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- APO-E antibody can be used for detection of APO-E by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- APO-E Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- APO-E antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- APOE (Apolipoprotein E (APOE))
-
Andere Bezeichnung
- APO-E
-
Hintergrund
- APO-E Antibody: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E (APO-E), a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in APO-E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.
-
Molekulargewicht
-
Predicted: 35 kDa
Observed: 34 kDa -
Gen-ID
- 348
-
NCBI Accession
- NP_000032
-
UniProt
- P02649
-
Pathways
- Regulation of Cell Size, Lipid Metabolism
Target
-